BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34473867)

  • 21. DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
    Yu J; Qin B; Moyer AM; Nowsheen S; Liu T; Qin S; Zhuang Y; Liu D; Lu SW; Kalari KR; Visscher DW; Copland JA; McLaughlin SA; Moreno-Aspitia A; Northfelt DW; Gray RJ; Lou Z; Suman VJ; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    J Clin Invest; 2018 Jun; 128(6):2376-2388. PubMed ID: 29708513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
    Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
    Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation.
    Liu T; Wang J; Sun L; Li M; He X; Jiang J; Zhou Q
    Cell Cycle; 2021 Aug; 20(16):1603-1616. PubMed ID: 34313525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells.
    Chatterjee B; Ghosh K; Swain A; Nalla KK; Ravula H; Pan A; Kanade SR
    Phytomedicine; 2022 Jan; 95():153885. PubMed ID: 34920321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
    Mahmood N; Arakelian A; Cheishvili D; Szyf M; Rabbani SA
    J Cell Mol Med; 2020 Sep; 24(18):10322-10337. PubMed ID: 32720467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9.
    Lin C; Xie Y; Huang W; Lin D; Lin L
    Exp Hematol; 2022 Oct; 114():43-53.e2. PubMed ID: 35908628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function of DNA methyltransferase 3a in lead (Pb(2+) )-Induced Cyclooxygenase-2 gene.
    Tsai YT; Chang CM; Wang JY; Hou MF; Wang JM; Shiurba R; Chang WC; Chang WC
    Environ Toxicol; 2015 Sep; 30(9):1024-32. PubMed ID: 24639330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of
    Tomela K; Karolak JA; Ginter-Matuszewska B; Kabza M; Gajecka M
    Curr Issues Mol Biol; 2021 Jun; 43(1):276-285. PubMed ID: 34204856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
    Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
    Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
    Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
    Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
    Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
    Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting DNA methylation for treating triple-negative breast cancer.
    Yu J; Zayas J; Qin B; Wang L
    Pharmacogenomics; 2019 Nov; 20(16):1151-1157. PubMed ID: 31755366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
    Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
    Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of androgen receptor transcription through the E2F1/DNMT1 axis.
    Valdez CD; Davis JN; Odeh HM; Layfield TL; Cousineau CS; Berton TR; Johnson DG; Wojno KJ; Day ML
    PLoS One; 2011; 6(9):e25187. PubMed ID: 21966451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion.
    Vijayaraghavalu S; Labhasetwar V
    Cancer Lett; 2013 Apr; 331(1):122-9. PubMed ID: 23305699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line.
    Pal D; Sur S; Roy R; Mandal S; Kumar Panda C
    J Cell Physiol; 2018 Jan; 234(1):825-836. PubMed ID: 30078217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.